City

Gainesville (1)

Houston (1)

Los Angeles (1)

Washington (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

M.D. Anderson Cancer Center (1)

University of Florida (1)

Washington University School of Medicine (1)

Collaborator

United States Department of Defense (1)

Intervention

erlotinib (1)

etoposide (1)

temozolomide (1)

ttrna-dcs (1)

ttrna-xalt (1)

valproate (1)

Study Documents

Intervention Type

biological (2)

drug (2)

Funder Type

Other (3)

Study Type

Interventional (3)

neuroectodermal tumor

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

Active, not recruiting

Has Results

Medulloblastoma
Neuroectodermal Tumor

TTRNA-xALT
TTRNA-DCs

Los Angeles, California
+2 more

Jan 7, 2022

Glioma, Rhabdomyosarcoma, Osteosarcoma Trial (Erlotinib, Temozolomide)

Withdrawn

Glioma
+7 more

Erlotinib
Temozolomide

(no location specified)

Sep 5, 2019

Neuroectodermal Tumor, Brain Metastases, Advanced Cancer Trial in Houston (Valproate, Etoposide)

Completed

Neuroectodermal Tumor
+2 more

Houston, Texas

UT MD Anderson Cancer Center

Sep 18, 2012